REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N107 (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N107 Profile Updated: August 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Russian Download a sample report

MUP Apteka N107 is an enterprise located in Russia, with the main office in Sakha (Yakutia) Republic. It operates in the Pharmacies and Drug Stores sector. It was first established on May 15, 2002. There was a net sales revenue drop of 5.13% reported in MUP Apteka N107’s latest financial highlights for 2022. Its total assets decreased by 3.09% over the same period. The net profit margin of MUP Apteka N107 increased by 3.88% in 2022.

Headquarters
Belaya Gora, I.N.Efimova, 13/1
Sakha (Yakutia) Republic; Sakha (Yakutia) Republic; Postal Code: 678890

Contact Details: Purchase the MUP Apteka N107 report to view the information.

Basic Information
Outstanding Shares:
Purchase the MUP Apteka N107 report to view the information.
Registered Capital:
Purchase the MUP Apteka N107 report to view the information.
Incorporation Date:
May 15, 2002
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Apteka N107 report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-5.13%
Total operating revenue
-5.13%
Operating profit (EBIT)
63%
Net Profit (Loss) for the Period
63%
Total assets
-3.09%
Total equity
-3.09%
Operating Profit Margin (ROS)
3.88%
Net Profit Margin
3.88%
Return on Equity (ROE)
14.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?